Amjad Ali Khan’s fundraiser Sept. 3 at the Tempe Center for the Arts will help hundreds of Arizona children with rare medical disorders

Amjad Ali Khan’s fundraiser Sept. 3 at the Tempe Center for the Arts will help hundreds of Arizona children with rare medical disorders

TEMPE, Ariz. - July 19, 2016 - Sarod virtuoso Amjad Ali Khan - who has graced the most celebrated stages of the globe and shared musical billings with artists as varied as Queen Latifah and Steven Tyler - will perform a benefit concert for the Translational Genomics Research Institute (TGen).

Khan and other Indian classical musicians will perform at 7 p.m. Sept. 3 at the Tempe Center for the Arts, 700 W. Rio Salado Parkway, to benefit TGen's Center for Rare Childhood Disorders (C4RCD).

 "Sarod for C4RCD" will feature: a solo by Khan on his lute-like stringed instrument; a duet by his son, seventh-generation sarod master Ayaan Ali Bangash, and Grammy-nominated violinist Elmira Darvarova; and a third set with all three musicians plus tabla (Indian two-piece drum) extraordinaire Anubrata Chatterjee.

"It is indeed a matter of great joy and honor for me to present my music for the music lovers of Phoenix," said Khan. "I am so humbled to be associated with the Center for Rare Childhood Disorders at TGen."

He was invited to perform in Phoenix at the benefit concert by Indian-born Dr. Vinodh Narayanan, Medical Director of TGen's C4RCD, which since 2012 has harnessed the latest in genomic sequencing technology to pinpoint the genetic causes of rare medical disorders.

"This music from my beloved India reaches in and touches the soul; it is something anyone can appreciate and enjoy," said Dr. Narayanan. "The fact that it will be performed by the world's top artists makes this fundraising event something not to be missed. It is indeed a chance of a lifetime for all of us in Arizona. It's an event that will benefit hundreds of children struggling to survive rare and difficult-to-treat medical conditions."

Khan has performed at: the WOMAD (World of Music, Arts and Dance) Festival in Adelaide, Australia, and New Plymouth, New Zealand; Edinburgh International (Music) Festival in Scotland; World Beat Festival in Brisbane, Australia, and Taranaki, New Zealand; The BBC Proms in London; Shiraz Arts Festival in Iran; Hong Kong Arts Festival; Adelaide Music Festival; 1200 Years celebration of Frankfurt; WOMAD Festival in Rivermead, England; and the Schonbrunn Palace in Vienna.

He has been a regular performer at Carnegie Hall in New York, Royal Albert Hall in London, the Kennedy Center in Washington, D.C., Victoria Hall in Geneva, Chicago Symphony Center, Mozart Hall in Frankfurt, and the Sydney Opera House in Australia.


In 2014, Amjad Ali Khan and his sons, Amaan Ali Bangash and Ayaan Ali Bangash, performed at the prestigious Nobel Peace Prize ceremony in Oslo, Norway, as well as the Nobel Peace Prize Concert along with a lineup that included Queen Latifah, Steven Tyler, Nuno Bettencourt and Laura Mvula.

In January, Khan performed for His Holiness The Dalai Lama's 80th birthday celebration in New Delhi.
 
Tickets for the Sept. 3 concert are $200, $150 and $100 with all proceeds benefiting TGen's Center for Rare Childhood Disorders. Tickets may be purchased at the Tempe Center for the Arts box office, by telephone at 480-350-2TCA (2822) or online at http://tca.ticketforce.com/SARODforC4RCD.

Food and beverages will be available for purchase.

For more information about these artists, please visit: www.sarod.com.

# # #

About TGen's Center for Rare Childhood Disorders
TGen's Center for Rare Childhood Disorders (C4RCD) applies the latest tools of genomic sequencing to provide answers for parents seeking to identify the disease or disorder affecting their child. Patients are clinically evaluated and families are enrolled for whole exome sequencing, which spells out individual's DNA genetic code for more than 20,000 genes.  The process, results, implications for the family, and next steps towards treatment are all discussed with the family in a very personal manner.  This is the goal of "personalized medicine."  If the sequencing reveals a genetic target, C4RCD scientists search existing FDA-approved drugs for a  compound that may be useful to treat the rare disorder. If no drug exists, we work with experts to develop new treatments tailored for each child's needs.

About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org. Follow TGen on FacebookLinkedIn and Twitter @TGen.

Media Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org


Search



Media Contact



RSS Feed

Newsletter